Plasma proteomics of _APOE_ genotype: age-specific analyses in UK population-based cohorts

Amy Packer, Tahsina Khatun, James W Groves, Tony Wyss-Coray, Jonathan M Schott, Petroula Proitsi, Emma L Anderson, Dylan M Williams

BACKGROUND: The apolipoprotein E (APOE) locus is the strongest genetic risk factor for late-onset Alzheimer's disease (AD). Variation in APOE isoforms is known to have diverse pleiotropic effects on circulating lipids and other metabolites, but effects on the circulating proteome across the life course are not well characterised. We investigated the specific effects of APOE ε4 and APOE ε2 carriage on the circulating proteome in middle-age and later life.